SIGILON THERAPEUTICS INC (SGTX)
US82657L2060 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to SGTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 48.28. This target is 114.86% above the current price.
SGTX was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SGTX.
In the previous month the buy percentage consensus was at a similar level.
SGTX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-07-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-07-03 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-06-30 | BTIG | Downgrade | Buy -> Neutral |
| 2023-06-30 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-05-26 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-05-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-01-18 | Canaccord Genuity | Initiate | Buy |
| 2021-12-23 | Canaccord Genuity | Maintains | Buy |
| 2021-12-01 | Barclays | Maintains | Overweight |
| 2021-11-30 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-11-30 | Jefferies | Downgrade | Buy -> Hold |
| 2021-10-29 | BTIG | Initiate | Buy |
| 2021-07-19 | Canaccord Genuity | Maintains | Buy |
| 2021-07-16 | Morgan Stanley | Maintains | Equal-Weight |